Woytek Bartkowski

Woytek Bartkowski has a diverse work experience spanning different industries and roles. Woytek is currently the Chief Technology Officer and Founder of Diadem Biotherapeutics, a company that develops biotherapeutic exosomes for cancer and other conditions. Woytek'sresponsibilities include leading the R&D and PD program and translating discoveries into valuable company assets.

Prior to this, Woytek worked as a Faculty member at John Tyler Community College from July 2017 to June 2019 and at Los Angeles Valley College in 2016. Woytek also served as a Technical Advisor at Kleinberg and Lerner, LLP from June 2014 to October 2016.

Woytek has a background in academia, with roles as a Postdoctoral Scholar and Teaching Assistant at UCLA from August 2012 to June 2014. Woytek also worked as a Teaching Assistant/Associate at UCLA from September 2000 to March 2009.

Additionally, Woytek gained industry experience as a Development Executive in Science Communication at Tone Mesa Media from October 2011 to March 2012, and as a Research Intern at Amgen in September 2007.

Woytek Bartkowski holds a Ph.D. in Microbiology, Immunology, and Molecular Genetics from UCLA, which they completed in 2010. Prior to that, they also obtained a Bachelor's Degree in Microbiology and Molecular Genetics from UCLA in 2000.